Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders.
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
06 Jun 2023
06 Jun 2023
Historique:
received:
20
05
2023
accepted:
30
05
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Hematology represents a dynamic specialty in clinical medicine that requires solid knowledge of normal and pathological hematopoiesis, cytomorphology, pathology, immunology, genetics and molecular biology [...].
Identifiants
pubmed: 37372964
pii: ijms24129816
doi: 10.3390/ijms24129816
pmc: PMC10298033
pii:
doi:
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Références
World J Clin Cases. 2023 Jan 16;11(2):268-291
pubmed: 36686358
Int J Mol Sci. 2022 Apr 08;23(8):
pubmed: 35456969
Int J Mol Sci. 2022 Aug 14;23(16):
pubmed: 36012375
Int J Mol Sci. 2022 Jul 11;23(14):
pubmed: 35886999
Int J Mol Sci. 2022 Jun 24;23(13):
pubmed: 35806064
Cancers (Basel). 2022 Jul 25;14(15):
pubmed: 35892871
Life (Basel). 2021 Jul 10;11(7):
pubmed: 34357048
Int J Mol Sci. 2020 Apr 29;21(9):
pubmed: 32365599
Int J Mol Sci. 2022 Jun 17;23(12):
pubmed: 35743211
Int J Mol Sci. 2022 Mar 03;23(5):
pubmed: 35269943
Cell Death Discov. 2022 Sep 26;8(1):397
pubmed: 36163119
Int J Mol Sci. 2022 Jun 30;23(13):
pubmed: 35806290
Int J Mol Sci. 2019 Jun 10;20(11):
pubmed: 31185671